荷兰Delft Imaging Systems   
Delft DI 专门从事两个领域的业务。第一个领域是为共用数位影像和医疗记录推出具有创新色彩的医疗软体解决方案。这项业务未来将变成开发新式医疗保健ICT（资讯通信技术）解决方案（包括跨企业共用成像文档(XDSI) 解决方案）的平台。

第二个领域是多种医院放射科定制解决方案的数位X 射线成像系统、系统集成及服务。在过去十年里，Delft DI 一直都是佳能(Canon) 数位放射成像系统在荷兰和比利时的分销合作伙伴。 Delft DI 已经将佳能数位放射成像产品纳入该公司的服务之中，而数位X 射线成像系统这项业务将在Delft DI 和Canon Europe 合作的基础上继续发展，并将成为开发未来数位放射成像服务的一大平台。

Delft Imaging Systems is part of Delft Diagnostic Imaging and finds its origin from Oldelft, the company that introduced the world-famous Odelca chest screening camera system in 1950. As a System Integrator we have developed a sharp eye for the practical needs of our customers. This has resulted in market-oriented structure of the company and in products and services which truly extend the boundaries of the possible. Our digital X-ray platform gives Delft a vital advantage over the competitors providing innovative solutions to the limitations that exist on the wider use of digital X-rays. Limitations such as non-availability at peripheral health facilities and the difficulty of interpreting results, even by trained physicians. Delft Imaging Systems is constantly developing new services and products for customers around the globe, has sufficient and adequate facilities and highly qualified personnel to carry out the specific training and application courses for the equipment involved. Traditionally we have a strong network of distributors and agents all around the world. We work closely with various stakeholders and prestigious international institutes that recognize the potential key benefits of direct digital radiology in low resource setting. Investments in low resource setting are often made by governments with financial support of the Global Fund, Gates foundation, programs like ORIO and others. All these donors are advised for their (annual) investments by organizations like the IUATLD and KNCV. Delft has most excellent relations with these donors and with KNCV and IUATLD. Delft Imaging Systems is the only imaging company worldwide to invest in solutions that assist the medical community in the fight against tuberculosis.